XML 17 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Revenue $ 1,067,471 $ 678,668 $ 2,819,163 $ 1,595,304
Costs and expenses:        
Cost of revenue 443,473 293,095 1,301,095 796,959
Research and development 412,021 283,639 1,131,272 783,115
Sales and marketing 217,526 143,511 547,536 397,834
General and administrative 175,275 126,287 516,202 382,232
Total costs and expenses 1,248,295 846,532 3,496,105 2,360,140
Operating loss (180,824) (167,864) (676,942) (764,836)
Interest income 1,257 2,801 3,645 16,158
Interest expense (4,031) (28,212) (13,626) (68,052)
Other income (expense), net 112,631 (5,669) 176,971 (14,483)
Loss before income taxes (70,967) (198,944) (509,952) (831,213)
Income tax benefit (expense) (992) (909) (553) (527)
Net loss $ (71,959) $ (199,853) $ (510,505) $ (831,740)
Net loss per share attributable to Class A, Class B, and Class C common stockholders (Note 3):        
Basic $ (0.05) $ (0.14) $ (0.33) $ (0.58)
Diluted $ (0.05) $ (0.14) $ (0.33) $ (0.58)
Weighted average shares used in computation of net loss per share:        
Basic 1,580,966 1,466,420 1,543,568 1,446,040
Diluted 1,580,966 1,466,420 1,543,568 1,446,040